Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Self-Compassion, Health, and Empowerment

Intimate partner violence (IPV) can have serious and lasting effects on women's mental health and well-being. Chinese immigrant women in the United States often face additional barriers to obtaining IPV and mental health support, including language, cultural, and social challenges. There is a need for culturally appropriate interventions that improve access to care and address the mental health needs of this underserved population. The purpose of this study is to evaluate the efficacy of the Self-Compassion, Health, and Empowerment (SHE) intervention, a culturally tailored mobile health (mHealth) program designed for Chinese immigrant women experiencing IPV. Participants will be randomly assigned to either the SHE intervention or an attention control program and will complete study assessments over a 12-month follow-up period. The results of this study will help determine whether the SHE intervention improves mental health and well-being among Chinese immigrant women experiencing IPV and may provide evidence for an accessible, culturally appropriate intervention that can be implemented more broadly.

Participants needed: 364
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Yang LiUpdated: Jul 30, 2026Locations: 1
Eligibility criteria

Age 18 or older; [+5]

Those who cannot speak or understand Mandarin or English; [+1]

Status: Recruiting

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

This prospective, single-arm, multi-center clinical trial aims to explore and evaluate the efficacy and safety of arsenic trioxide combined with chemotherapy for pediatric cancer with p53 mutation.

Participants needed: 50
Trial details
Phase: Phase 2Age: Up to 18Biological sex: AllType: InterventionalSponsor: Yang LiUpdated: Jan 3, 2024Locations: 1
Eligibility criteria

Pathological diagnosis basis of malignant tumor; [+4]